Welcome to our dedicated page for Hippo Hldgs SEC filings (Ticker: HIPO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Insurance disclosures seldom feel straightforward. Hippo Holdings weaves reinsurance treaties, Insurance-as-a-Service fees, and catastrophe loss tables into filings that sprawl across hundreds of pages. If you have searched “Hippo Holdings SEC filings explained simply” or hunted for the latest Hippo Holdings quarterly earnings report 10-Q filing, you know deciphering every footnote is tough.
Stock Titan removes that friction. Our AI-powered analysis condenses each Hippo Holdings annual report 10-K simplified, clarifies Hippo Holdings 8-K material events explained, and spotlights trends hidden in the numbers. Real-time alerts stream Hippo Holdings Form 4 insider transactions, so you track executive stock transactions Form 4 the moment they hit EDGAR. Need board-level pay details? We extract Hippo Holdings proxy statement executive compensation metrics into crisp tables, while interactive charts power a Hippo Holdings earnings report filing analysis in minutes.
Whether you’re monitoring Hippo Holdings insider trading Form 4 transactions before a rating review or understanding Hippo Holdings SEC documents with AI to gauge loss-ratio improvements, all filings arrive seconds after EDGAR posts. Use them to:
- Compare segment revenue between IaaS fees and underwriting results quarter over quarter
- Track how smart-home risk programs affect claim frequency
- Correlate catastrophe exposure with reinsurance costs across filings
Every document is searchable, summarized and paired with expert context—no more weekend-long PDF dives. Complex disclosures become clear, empowering you to make well-informed decisions faster.
Hippo Holdings Inc. (HIPO) reported a sharp turnaround in Q3 2025, posting net income of $98.1 million versus a loss a year ago, as total revenue rose to $120.6 million from $95.5 million. Results were driven by a $95.0 million gain on the sale of its homebuilder distribution network, while underlying insurance metrics also improved: net earned premium reached $99.7 million (from $70.6 million) and losses and LAE fell to $47.5 million (from $51.6 million).
The balance sheet strengthened with total assets of $1.87 billion and Hippo stockholders’ equity of $421.5 million. Cash and cash equivalents increased to $247.7 million, supported by $75 million upfront proceeds from the sale and a new $50.0 million surplus note at a 9.5% fixed rate. The company repurchased 514,309 shares for $14.5 million and ended the quarter with 25,337,366 shares issued and outstanding. Hippo also simplified reporting to a single segment, reflecting how leadership now manages the business.
Hippo Holdings Inc. furnished an 8‑K announcing it issued materials for its quarter ended September 30, 2025. The company provided a press release, an investor presentation, and historical supplemental financial information.
The materials include non‑GAAP financial measures with reconciliations to GAAP. The information in Item 2.02 and Exhibits 99.1, 99.2, and 99.3 is furnished, not filed, and is not incorporated by reference unless specifically stated.
Hippo Holdings Inc. (HIPO) reported a director equity award on Form 4. On 10/01/2025, the director acquired 2,502 shares of Common Stock at $0.00, reported as a grant of restricted stock units (RSUs).
Each RSU converts into one share upon vesting, which occurs on the earlier of the first anniversary of the grant date or immediately prior to the next Annual Meeting following the grant, subject to continued service. After the reported transaction, 2,502 securities were beneficially owned, held directly.
Hippo Holdings Inc. (HIPO) reported a director’s equity award on a Form 4. On 10/01/2025, the reporting person acquired 2,502 shares of Common Stock via restricted stock units (RSUs) at $0.00 per unit.
The RSUs vest in full upon the earlier of the first anniversary of the grant date or immediately prior to the Annual Meeting following the grant, subject to continued service. Following the reported transaction, the reporting person beneficially owned 2,502 shares, held as direct ownership.
Hippo Holdings (HIPO) reported a Form 3 for director Susan Claire Holliday, effective 10/01/2025. The filing states that no securities are beneficially owned. This is an initial statement under Section 16 and was filed by one reporting person.
Hippo Holdings Inc. (HIPO) Form 3 filed for Laura J. Hay, who is identified as a Director. The event date triggering the filing is 10/01/2025. The filing states that no securities are beneficially owned by the reporting person as of the event date. The form was signed by Guy Zeltser, Attorney-in-Fact on 10/03/2025.
Hippo Holdings Inc. insider Guy Zeltser, the company's Chief Financial Officer, reported sales of common stock on 09/17/2025 executed under a Rule 10b5-1 trading plan dated June 18, 2025. The Form 4 shows two sale line items totaling 5,177 shares sold at weighted average prices of $37.4569 and $38.045, leaving the reporting person with 74,861 shares beneficially owned after the transactions.
The filing notes that the remaining holdings include 65,817 RSUs. The reporting person certified the sales and provided undertakings to supply trade-level details on request.
Hippo Holdings Inc. (HIPOW) submitted a Form 144 disclosing a proposed sale of 5,177 common shares by a person for whose account the securities are to be sold. The shares have an aggregate market value of $192,636.17 based on the filing, against 25,028,054 shares outstanding. The proposed approximate sale date is 09/17/2025 on the NYSE. The shares were acquired from the issuer as restricted stock units on 02/15/2025 and were paid in full on that date. The filer reports no securities sold in the past three months for the account.
Michael Stienstra, an officer of Hippo Holdings Inc. (HIPO), reported a change in beneficial ownership on a Form 4 related to a transaction dated 09/10/2025. The filing shows a disposition of 752 shares of Hippo common stock at a price of $36.97 each. After the reported transaction, Mr. Stienstra beneficially owns 77,644 shares, which the filing states includes 44,246 RSUs. The Form 4 was signed by an attorney-in-fact, Guy Zeltser, on 09/11/2025. No additional transactions, derivative holdings, or explanatory details beyond the RSU component are provided in the text.
Torben Ostergaard, listed as an officer (CEO Spinnaker) of Hippo Holdings Inc. (HIPO), reported a sale of common stock on 09/10/2025. The Form 4 shows 1,358 shares disposed at a price of $36.97 per share, reducing his direct holdings to 60,975 shares after the transaction. The filing notes those holdings include 52,671 RSUs, and the form was signed on behalf of Mr. Ostergaard by an attorney-in-fact, Guy Zeltser, on 09/11/2025.
The report is a standard Section 16 disclosure of an insider sale and provides explicit details on the number of shares sold, sale price, and resulting beneficial ownership. No derivative transactions or additional material terms are reported in this filing.
FAQ
What is the current stock price of Hippo Hldgs (HIPO)?
What is the market cap of Hippo Hldgs (HIPO)?
